Award
NIH Reporter #5R35CA263922-04
Interaction between nuclear epigenetic and metabolic pathways in cancer
Recipient
Shelley L Berger
Award Amount
$974,274.00
Ceiling
$974,274.00
Awarded
September 02, 2025
Identifier
5R35CA263922-04
Research project funded by the National Cancer Institute to study the interaction between nuclear epigenetic and metabolic pathways in cancer, led by Shelley L Berger at the University of Pennsylvania, with an award amount of $974,274 for FY 2025.
Description
The project focuses on investigating the intersection of epigenetic regulation and nuclear metabolism in cancer. The research aims to uncover novel mechanisms involved in tumor formation and develop potential therapeutic strategies. The project involves multidisciplinary approaches and bridges cancer biology with epigenetics and metabolism. The work is supported by the National Cancer Institute under grant PAR-21-333. The project is led by Shelley L Berger at the University of Pennsylvania. The award is scheduled for FY 2025, with a project duration until August 2029. The funding is for research involving cancer biology, genetics, and biotechnology.